Serotransferrin
TFproteinSerotransferrin distinguishes Type 1 MI from other troponin-elevated diseases via differential iron-handling and systemic metabolic responses independent of atherothrombotic pathophysiology.
Pathway placement
Cascade stepOff-pathway / systemic markers
Confidencelow
RationaleDifferential diagnostic marker; off-pathway iron metabolism/systemic.
Druggability
Not assessed (no mapped human gene target).
Assay & specimen
Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Serum or plasma
Collection tube
Serum separator (gold/red-top, SST) · K2/K3-EDTA (lavender-top)
Method / principle
Sandwich immunoassay (ELISA) — research-grade unless a cleared assay exists
Reagent / substrate
Matched anti-target antibody pair (capture + labeled detection)
Platform
ELISA microplate or multiplex (Luminex/MSD)
Turnaround · availability
Send-out / research · Research-grade (no universal clinical assay)
Literature evidence(1)
- Potential Biomarkers to Distinguish Type 1 Myocardial Infarction in Troponin-Elevated Diseases.International journal of molecular sciences · 2023 · PMID 37175804 · doi